Call us at (860) 830-7838
Behavioral Wellness Clinic

MENTAL HEALTH & COUNSELING SERVICES IN CONNECTICUT AND ONLINE


Psychedelic Medicine

MDMA-Assisted Psychotherapy for PTSD

Dr. Monnica Williams and Sara Reed are part of an FDA approved clinical trial of MDMA-assisted psychotherapy for PTSD that is taking place at the University of Connecticut Health Center (UCHC) in the Department of Psychiatry, in Farmington, Connecticut. This is a cutting-edge treatment for people suffering from PTSD, grant-funded by the Multidisciplinary Association for Psychedelic Studies (MAPS).

Paradigm Shift in Mental Health Care

A program called Expanded Access (EA) allows the use of an investigational medical product (one that has not yet been approved by the FDA) outside of a clinical trial. The program’s purpose is to grant access to potentially beneficial investigational treatments for people facing a serious or immediately life-threatening condition for which there is no satisfactory treatment currently available.  In the coming year, MDMA is expected to be available for people who have not responded to traditional therapies for PTSD.

MAPS offers a Therapy Training Program for therapists who would like to begin offering MDMA to clients. Dr. Monnica Williams will co-lead a training event in 2019 specifically for therapy providers of color.

A group of mental health professionals.


Therapists at BWC are available to assist people who are working to integrate and resolve experiences involving non-ordinary states of consciousness.

Patient Stories

MDMA: Medicine for Healing from Trauma: Known on the street as Ecstasy, MDMA is found to promote recovery from posttraumatic stress disorder. Epigee Women's Health.

Media Coverage

Sullivan, K. (2018, October 1). Black Americans Are Being Left Out of Psychedelics Research. Vice Tonic.

Shastry, N. (2018, September 5). Taking psychedelic drugs to ease death. BeMe News/CNN.

Williams, M. T. (2018, August 24) Psychedelic Psychotherapy Is Coming: Who Will Be Included? A new study finds widespread exclusion of minorities in psychedelic research. Culturally Speaking Blog. Psychology Today.

Lekhtman, A. (2018, August 1). A healing trip: Psychologists are testing MDMA to treat the trauma of racism. Merry Jane.

Moore, J., & Buller, K. (2018, July 24). Exploring race-based traumatic stress and MDMA-assisted psychotherapy. Psychedelics Today.

Lekhtman, A. (2018, July 17). A psychedelic study in Connecticut aims to bridge the racial gap in MDMA psychotherapy. Psychedelic Times.

Krieger, K. (2018, July 16). Unraveling. UConn Health Journal.

Hellerman, C. (2016, December 1). Using Ecstasy to treat PTSD: I felt like my soul snapped back into place. PBS Newshour.

Publications

Williams, M. T., & Leins, C. (2016). Race-based trauma: The challenge and promise of MDMA-assisted psychotherapy. Multidisciplinary Association for Psychedelic Studies (MAPS) Bulletin, 26(1), 32-37.

Michaels, T. I., Purdon, J., Collins, A. & Williams, M. T. (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry, 18(245), 1-9. doi: 10.1186/s12888-018-1824-6.

BEHAVIORAL WELLNESS CLINIC

392 MERROW RD, SUITE E
TOLLAND, CT 06084
OFFICE: (860) 830-7838
FAX: (860) 454-0667

 
CLINICAL DIRECTOR: MONNICA WILLIAMS, PHD
OFFICE MANAGER: JASMINE FAIRFAX
BUSINESS MANAGER: MATTHEW JAHN

 
FRONT DESK PHONE HOURS
M: 12 noon - 3:00 pm
Tu: 8:30 am - 4:30 pm
W: 8:30 am - 3:00 pm
F: 8:30 am - 3:00 pm